AOLS — Aeolus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Aeolus Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	C2012 September 30th	2013 September 30th	2014 September 30th	2015 September 30th	2016 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.281	0.869	1.52	0.094	3.15
Net Total Accounts Receivable
Net Total Receivables	0.781	0.37	1.56	1.58	0.75
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.22	1.93	3.55	1.75	4.13
Long Term Investments
Total Assets	1.26	1.97	3.58	1.78	4.17
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.27	1.26	2	2.62	0.972
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.6	1.26	2	2.62	0.972
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-20.3	0.705	1.58	-0.845	3.19
Total Liabilities & Shareholders' Equity	1.26	1.97	3.58	1.78	4.17
Total Common Shares Outstanding
Total Preferred Shares Outstanding